KRAS and neoplasm: We found that the treatment with Kras-ASO-EVs, immR-EVs, or combination of Kras-ASO-EVs and immR-EVs significantly dampened tumor growth as compared to the control treatment with PBS or NC-ASO-EVs, as indicated by the significantly reduced tumor cell density within the lung (Figure 4B-C).